Literature DB >> 31405683

The prevalence of osteoporosis among Iranian postmenopausal women with type 2 diabetes: A systematic review and meta-analysis.

Naser Parizad1, Vajiheh Baghi2, Elnaz Baghban Karimi3, Reza Ghanei Gheshlagh4.   

Abstract

Osteoporosis is the most common metabolic bone disorder that is common in postmenopausal women with type 2 diabetes. Different studies have reported different prevalence of osteoporosis. This systematic review and meta-analysis was conducted to estimate the pooled prevalence of osteoporosis in Iranian postmenopausal women with type 2 diabetes. Search for eligible articles was performed using the keywords of osteoporosis, osteopenia, bone mineral density, OP, bone loss, Post menopaus*, diabetes, hyperglycemia, and Iran, and their possible combinations in the following databases: Scientific Information Database (SID), MagIran, PubMed, Scopus, and Web of Science. Heterogeneity between studies was examined with I2. The data were analyzed using the meta-analysis method and random effects model with Stata version 11.0. The analysis of 4 papers with a sample size of 562 showed that the prevalence of osteoporosis in the lumbar spine and femoral neck of the Iranian post-menopausal women with type II diabetes was 25.26% (95% CI: 7.22-30.30) and 17.45% (95% CI: 0.25-34.65), respectively. Also, the prevalence of osteopenia in the lumbar spine and femoral neck of these patients was 45.23% (95% CI: 40.66-49.79) and 44.53% (95% CI: 36.60-52.47), respectively. There was no relationship between the prevalence of osteoporosis and osteopenia with sample size, year of publication, age and body mass index. Osteoporosis and osteopenia are prevalent in women, so healthy lifestyle education for these postmenopausal women are necessary to reduce the prevalence of these problems.
Copyright © 2019 Diabetes India. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bone mineral density; Diabetes; Menopause; Osteopenia; Osteoporosis

Mesh:

Year:  2019        PMID: 31405683     DOI: 10.1016/j.dsx.2019.07.036

Source DB:  PubMed          Journal:  Diabetes Metab Syndr        ISSN: 1871-4021


  5 in total

1.  DPP4 Activities Are Associated with Osteopenia/Osteoporosis and Fracture Risk in Newly Diagnosed Type 2 Diabetes.

Authors:  Min Qiu; Shuheng Zhai; Da Liu
Journal:  Int J Endocrinol       Date:  2020-11-27       Impact factor: 3.257

2.  Insight into the roles of melatonin in bone tissue and bone‑related diseases (Review).

Authors:  Xiaofeng Lu; Shaoling Yu; Guangjin Chen; Wenhao Zheng; Jinfeng Peng; Xiaofei Huang; Lili Chen
Journal:  Int J Mol Med       Date:  2021-03-24       Impact factor: 4.101

3.  Is diabetes mellitus a risk factor for low bone density: a systematic review and meta-analysis.

Authors:  Jingying Qiu; Chengjiang Li; Zhichun Dong; Jing Wang
Journal:  BMC Endocr Disord       Date:  2021-04-13       Impact factor: 2.763

4.  Risk of osteoporosis in patients with erectile dysfunction: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Jiangnan Xu; Chao Wang; Yuhui Zhang; Zekun Xu; Jun Ouyang; Jianglei Zhang
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

5.  A quinoxaline-based compound ameliorates bone loss in ovariectomized mice.

Authors:  Ying Zhou; Xiaoyan Xue; Yanyan Guo; Huan Liu; Zheng Hou; Zhou Chen; Ning Wang; Fen Li; Yang Wang
Journal:  Exp Biol Med (Maywood)       Date:  2021-07-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.